281 related articles for article (PubMed ID: 25026291)
1. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A; Schlößer HA; Gryschok L; Malcher J; Wennhold K; Garcia-Marquez M; Herbold T; Neuhaus LS; Becker HJ; Fiedler A; Scherwitz P; Koslowsky T; Hake R; Stippel DL; Hölscher AH; Eidt S; Hallek M; Theurich S; von Bergwelt-Baildon MS
Oncotarget; 2014 Jul; 5(13):4651-64. PubMed ID: 25026291
[TBL] [Abstract][Full Text] [Related]
2. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies.
Zirakzadeh AA; Marits P; Sherif A; Winqvist O
J Immunol; 2013 Jun; 190(11):5847-55. PubMed ID: 23630345
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Importance of CD20
Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
[TBL] [Abstract][Full Text] [Related]
4. A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases.
Montfort A; Pearce O; Maniati E; Vincent BG; Bixby L; Böhm S; Dowe T; Wilkes EH; Chakravarty P; Thompson R; Topping J; Cutillas PR; Lockley M; Serody JS; Capasso M; Balkwill FR
Clin Cancer Res; 2017 Jan; 23(1):250-262. PubMed ID: 27354470
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.
Liao Y; Ou J; Deng J; Geng P; Zeng R; Tian Y; Liang H; Ni B; Ruan Z
Med Oncol; 2013 Dec; 30(4):727. PubMed ID: 24026663
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.
Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M
In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794
[TBL] [Abstract][Full Text] [Related]
9. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis.
Corcione A; Ferlito F; Gattorno M; Gregorio A; Pistorio A; Gastaldi R; Gambini C; Martini A; Traggiai E; Pistoia V
Arthritis Res Ther; 2009; 11(5):R150. PubMed ID: 19804628
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
[TBL] [Abstract][Full Text] [Related]
14. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development.
Gonçalves IV; Pinheiro-Rosa N; Torres L; Oliveira MA; Rapozo Guimarães G; Leite CDS; Ortega JM; Lopes MTP; Faria AMC; Martins MLB; Felicori LF
Sci Rep; 2024 May; 14(1):11576. PubMed ID: 38773133
[TBL] [Abstract][Full Text] [Related]
16. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
Kemmerer CL; Pernpeintner V; Ruschil C; Abdelhak A; Scholl M; Ziemann U; Krumbholz M; Hemmer B; Kowarik MC
PLoS One; 2020; 15(7):e0235449. PubMed ID: 32716916
[TBL] [Abstract][Full Text] [Related]
18. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Cantero-Cid R; Casas-Martin J; Hernández-Jiménez E; Cubillos-Zapata C; Varela-Serrano A; Avendaño-Ortiz J; Casarrubios M; Montalbán-Hernández K; Villacañas-Gil I; Guerra-Pastrián L; Peinado B; Marcano C; Aguirre LA; López-Collazo E
BMC Cancer; 2018 Oct; 18(1):945. PubMed ID: 30285662
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Blumenfeld S; Staun-Ram E; Miller A
J Autoimmun; 2016 Jun; 70():40-51. PubMed ID: 27055778
[TBL] [Abstract][Full Text] [Related]
20. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
Mahalingam J; Lin CY; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Lin YC
PLoS One; 2014; 9(9):e108554. PubMed ID: 25268580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
